Literature DB >> 3456886

Isotretinoin in the treatment of steatocystoma multiplex: a possible adverse reaction.

B L Rosen, R H Brodkin.   

Abstract

A patient with steatocystoma multiplex (SM) with severe inflammation was treated with oral isotretinoin. Inflamed cysts markedly improved with treatment. However, after eight weeks of therapy, many pre-existing cysts rapidly enlarged and new cysts occurred. Therapy was then discontinued. Isotretinoin may have exacerbated or worsened this condition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456886

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  7 in total

Review 1.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

Review 2. 

Authors:  Jorge R Georgakopoulos; Arvin Ighani; Jensen Yeung
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

Review 3.  Numerous asymptomatic dermal cysts: Diagnosis and treatment of steatocystoma multiplex.

Authors:  Jorge R Georgakopoulos; Arvin Ighani; Jensen Yeung
Journal:  Can Fam Physician       Date:  2018-12       Impact factor: 3.275

4.  Multiple cream-colored papules over the trunk and neck.

Authors:  S Vijay Shankar; Kc Nischal; Mr Swaroop; Hb Basavaraj; Bd Sathyanarayana
Journal:  J Cutan Aesthet Surg       Date:  2009-07

5.  Fractionated ablative carbon dioxide laser treatment of steatocystoma multiplex.

Authors:  Sama Kassira; Dorota Z Korta; Sebastien de Feraudy; Christopher B Zachary
Journal:  J Cosmet Laser Ther       Date:  2016-07-19       Impact factor: 2.247

6.  An Unusual Case of Facial Steatocystoma Multiplex: A Clinicopathologic and Dermoscopic Report.

Authors:  Aseem Sharma; Sandip Agrawal; Rachita Dhurat; Dipti Shukla; Tejas Vishwanath
Journal:  Dermatopathology (Basel)       Date:  2018-05-22

7.  Familial Steatocystoma Multiplex Generalisita Suppuritiva: Oral Rifampicin and Clindamycin Combination Worth a Trial.

Authors:  Ghazal Ahmed; Neel Prabha; Satyaki Ganguly
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.